University of Texas to Contribute $25 to Prostate Cancer Research Institute per Participant in Active Surveillance Survey

Share Article

Through October 31, For Each Online Survey Completed By Prostate Cancer Patients and Survivors, PCRI will receive a $25 Contribution from the University of Texas

News Image

Prostate cancer patients and survivors now have an easy way to help the Prostate Cancer Research Institute through October 31. All they need to do is participate in a simple online survey, and PCRI will receive $25 for every person who completes it!

The Survey

Researchers from the University of Texas School of Public Health and University of Texas MD Anderson Cancer Center are working on a project funded by the Centers for Disease Control and Prevention (CDC) that seeks to develop balanced information about the advantages and disadvantages of active surveillance as a possible option for men diagnosed with early-stage prostate cancer.

They are currently testing different sets of information in a one-time web-based survey, and would like input from prostate cancer survivors.


To be eligible for participation in this project, a man has to have been diagnosed with early stage, localized prostate cancer and have completed treatment 6 months to 5 years earlier. The survey is anonymous and is expected to take no longer than 30 minutes to complete.

Researchers hope the study findings will help facilitate the design of better decision aids for men who are diagnosed with prostate cancer in the future.

The university will make a $25 contribution to the Prostate Cancer Research Institute for every survey completed.

How to Participate

For those interested in participating in the survey, please visit and complete the survey by Wednesday, October 31.


Men interested in participating may e-mail the survey administrators at ProstateCancerSurvey(at)uth.tmc(dot)edu with any questions.

About PCRI

The Prostate Cancer Research Institute is a charitable non-profit organization dedicated to supporting research to improve the quality of men’s lives, and providing information that both educates and empowers patients, families and the medical community. Founded in 1996 by internationally recognized prostate cancer oncologists Mark C. Scholz, MD and Stephen B. Strum, MD, with support from Daniel Freeman Hospital Foundation, PCRI provides programs and services to support their mission and goals. Such programs and resources include a help line, an informative and up-to-date website, newsletters, annual conferences, advocacy, and research.

For more information, visit

Share article on social media or email:

View article via:

Pdf Print

Contact Author